- Home
- ARQ vs XBIT Comparison
ARQ vs XBIT Comparison
Compare ARQ & XBIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQ
- XBIT
- Stock Information
- Founded
- ARQ 1996
- XBIT 2005
- Country
- ARQ United States
- XBIT United States
- Employees
- ARQ N/A
- XBIT N/A
- Industry
- ARQ
- XBIT Pharmaceuticals and Biotechnology
- Sector
- ARQ
- XBIT Health Care
- Exchange
- ARQ NYSE
- XBIT Nasdaq
- Market Cap
- ARQ 249.0M
- XBIT 242.2M
- IPO Year
- ARQ N/A
- XBIT 2015
- Fundamental
- Price
- ARQ $5.28
- XBIT $7.08
- Analyst Decision
- ARQ
- XBIT
- Analyst Count
- ARQ 0
- XBIT 0
- Target Price
- ARQ N/A
- XBIT N/A
- AVG Volume (30 Days)
- ARQ 367.3K
- XBIT 50.4K
- Earning Date
- ARQ 08-12-2024
- XBIT 11-07-2024
- Dividend Yield
- ARQ N/A
- XBIT N/A
- EPS Growth
- ARQ N/A
- XBIT N/A
- EPS
- ARQ N/A
- XBIT N/A
- Revenue
- ARQ $105,078,000.00
- XBIT N/A
- Revenue This Year
- ARQ $4.58
- XBIT N/A
- Revenue Next Year
- ARQ $40.31
- XBIT N/A
- P/E Ratio
- ARQ N/A
- XBIT N/A
- Revenue Growth
- ARQ 12.87
- XBIT N/A
- 52 Week Low
- ARQ $1.60
- XBIT $3.51
- 52 Week High
- ARQ $8.26
- XBIT $9.96
- Technical
- Relative Strength Index (RSI)
- ARQ 40.82
- XBIT 51.13
- Support Level
- ARQ $5.33
- XBIT $7.05
- Resistance Level
- ARQ $5.78
- XBIT $7.60
- Average True Range (ATR)
- ARQ 0.35
- XBIT 0.56
- MACD
- ARQ -0.02
- XBIT -0.03
- Stochastic Oscillator
- ARQ 37.82
- XBIT 49.40
About ARQ ARQ INC
Arq Inc is an environmental technology company principally engaged in the sale of consumable air, water, and soil treatment solutions including activated carbon (AC) and chemical technologies. The company manufactures and sells activated carbon and other chemicals used to capture and remove contaminants for the coal-fired power generation, industrial, municipal water and air, water and soil treatment and remediation markets. Some of the products in its portfolio are Powdered Activated Carbon, Granular Activated Carbon, and Colloidal Carbon Product among others.
About XBIT XBiotech Inc.
XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-IL-1 a therapeutic antibody as a treatment for cancer. Geographically, all of its operations are in the United States.